Exagen Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
XGN Nasdaq 3840 www.exagen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Exagen Inc.

What New Catalysts Are Shaping the Narrative for Exagen? - Dec 7th, 2025 5:10 pm
Why Analysts Are Updating Exagen’s Story After Higher Targets and Growth Outlook - Nov 23rd, 2025 1:06 pm
Exagen Inc. to Participate in Fourth Quarter Investor Conferences - Nov 11th, 2025 7:00 am
How Analyst Views Are Shifting the Story for Exagen Amid New Growth Signals - Nov 7th, 2025 12:13 am
Exagen (XGN): Revenue Growth Outlook Challenges Bearish Sentiment as Valuation Remains Undemanding - Nov 4th, 2025 5:25 pm
Exagen Inc (XGN) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Expansion ... - Nov 4th, 2025 2:08 pm
Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates - Nov 4th, 2025 7:10 am
Exagen Inc. Reports Strong Q3 2025 Results - Nov 4th, 2025 6:00 am
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence - Oct 23rd, 2025 7:15 am
How the Narrative Around Exagen Is Shifting With Analyst Upgrades and Growth Signals - Oct 22nd, 2025 11:07 pm
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025 - Oct 21st, 2025 2:05 pm
With 38% stake, Exagen Inc. (NASDAQ:XGN) seems to have captured institutional investors' interest - Oct 2nd, 2025 4:55 am
[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Aug 12th, 2025 8:30 pm
Exagen Inc. to Participate in Third Quarter Investor Conferences - Aug 6th, 2025 2:05 pm
Exagen Inc. (XGN) Reports Q2 Loss, Beats Revenue Estimates - Jul 29th, 2025 7:10 am
Exagen Inc. Reports Strong Q2 2025 Results - Jul 29th, 2025 6:00 am
Exagen Inc. (XGN): A Bull Case Theory - Jul 24th, 2025 7:09 am
Exagen (XGN) Soars 5.5%: Is Further Upside Left in the Stock? - Jul 24th, 2025 6:45 am
Exagen Inc. Appoints Chas McKhann to Board of Directors - Jul 17th, 2025 2:05 pm
Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025 - Jul 15th, 2025 2:05 pm